☆ 4.7 Review

Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways

BIOMOLECULES (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy

Manman Ma et al.

Summary: A novel tT beta RII variant, Z-tT beta RII, was designed by fusing the PDGF beta receptor-specific affibody Z(PDGF beta R) to the N-terminus of tT beta RII. Z-tT beta RII exhibited superior specific fibrotic liver-targeting potential and stronger anti-fibrotic effects in vitro and in vivo. It also showed no significant sign of potential side effects in other vital organs in liver fibrotic mice, making it a potential candidate for targeted therapy for liver fibrosis.

ARCHIVES OF PHARMACAL RESEARCH (2023)

Add to Collection

Article Medicine, Research & Experimental

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy

Fariha Alam et al.

Summary: This study found that B7-33 can retain the cardioprotective effects of RLX and has a better therapeutic effect compared to the ACE inhibitor perindopril. Therefore, B7-33 could be considered as a cost-effective cardioprotective therapy.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Petra Verdino et al.

Summary: Chronic heart failure, especially in heart failure with preserved ejection fraction, lacks effective treatment options and poses a burden on patients and society. LY3540378, a long-acting relaxin analogue, has shown promising results in preclinical studies and is progressing in clinical trials, offering a potential therapeutic approach for chronic heart failure.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Add to Collection

Article Orthopedics

PAI-1 mediates TGF-beta 1-induced myofibroblast activation in tenocytes via mTOR signaling

Rahul G. Alenchery et al.

Summary: This study found that transforming growth factor-beta (TGF-beta 1) induces plasminogen activator inhibitor 1 (PAI-1) to inhibit phosphatase and tensin homolog (PTEN), suggesting that PAI-1-induced adhesions involve phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (mTOR) signaling. PAI-1 deletion blunted TGF-beta 1-induced myofibroblast activation in murine flexor tenocytes and increased the gene expression of Mmp-2 to confer protective effects against fibrosis. While TGF-beta 1 significantly reduced phosphorylation of PTEN in WT cells, PAI-1 deletion rescued the activation of PTEN.

JOURNAL OF ORTHOPAEDIC RESEARCH (2023)

Add to Collection

Article Materials Science, Biomaterials

Bioactive fibrous scaffolds with programmable release of polypeptides regulate inflammation and extracellular matrix remodeling

Zehong Xiang et al.

Summary: Inflammation manipulation and extracellular matrix (ECM) remodeling are critical for tissue engineering scaffolds. In this study, bioactive polycaprolactone (PCL)-based scaffolds were fabricated to release aprotinin and thymosin beta 4 (T beta 4) in a controlled manner. The release of aprotinin prevented excessive inflammation, while the subsequent release of T beta 4 induced the transition of macrophages and controlled ECM remodeling. The gradual degradation of the scaffold allowed cell proliferation. In vivo implant evaluation confirmed that PCL-based scaffolds effectively controlled inflammation and restored the ECM. Therefore, our work presents a new approach for tissue engineering scaffolds with peptide-mediated reactions for inflammation manipulation and ECM remodeling.

REGENERATIVE BIOMATERIALS (2023)

Add to Collection

Article Cell Biology

Intermedin1-53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis

Lin-Shuang Zhang et al.

Summary: Intermedin (IMD) protects against cardiac fibrosis by inhibiting NLRP3 inflammasome activation and endoplasmic reticulum stress (ERS). IMD treatment improves cardiac function and reduces myocardial interstitial collagen deposition.

INFLAMMATION (2022)

Add to Collection

Review Medicine, Research & Experimental

Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives

Chiara Sassoli et al.

Summary: Relaxin, a potential medication for fibrotic diseases, has shown promising results in in vitro and in vivo studies by inhibiting fibrogenic pathways and activating fibrosis-generating cells. However, clinical trials have yielded inconclusive results. This review summarizes the molecular mechanisms of fibrosis and critically evaluates the clinical trials, identifying future opportunities for the therapeutic use of relaxin.

CURRENT MOLECULAR MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling

Qian Yuan et al.

Summary: Loss of Klotho protein is involved in the development of chronic kidney diseases. Researchers have discovered a peptide called KP1 derived from Klotho protein that protects the kidneys by targeting the TGF-beta signaling pathway. KP1 inhibits TGF-beta signaling, prevents fibrosis, and improves kidney function.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Prokaryotic expression, purification and evaluation of anti-cardiac fibrosis activity of recombinant TGF-β latency associated peptide

Xudong Song et al.

Summary: Recombinant LAP was successfully expressed and purified. The study found that recombinant LAP could effectively inhibit cell proliferation and decrease the expression levels of a-SMA, collagen I, fibronectin, and p-Smad2 in H9C2 cells induced by TGF-beta. These results suggest that recombinant LAP may inhibit TGF-beta-induced fibrosis through the TGF-beta/Smad pathway.

PEERJ (2022)

Add to Collection

Article Immunology

Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide

Fariba Poosti et al.

Summary: This study evaluated the applicability of a human peptide called CXCL9(74-103) for therapeutic intervention in renal fibrosis. The peptide was found to reduce fibroblast migration and the expression of related proteins, inhibit inflammation, and exert anti-fibrotic and anti-inflammatory effects through competition with chemokines and growth factors for glycosaminoglycan binding.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

BMP7-based peptide agonists of BMPR1A protect the left ventricle against pathological remodeling induced by pressure overload

Ana B. Salido-Medina et al.

Summary: This study investigated the therapeutic potential of BMP7-based peptides as cardioprotective drugs in the context of aortic stenosis. The results demonstrated that these peptides attenuated remodeling-related genes, alleviated structural damage, and improved LV dysfunction in animal models. They also showed potential in inhibiting hypertrophic gene program and collagen transcriptional activation.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Article Multidisciplinary Sciences

Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis

Jaiwoo Lee et al.

Summary: This study reports a targeted anti-fibrotic peptide-delivery system that effectively reduces liver fibrosis by utilizing fibroblast activation protein to release an antifibrotic peptide.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Caveolin-1 peptide regulates p53-microRNA-34a feedback in fibrotic lung fibroblasts

Taryn B. Hogan et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease caused by abnormal repair responses to lung injury. The expression of miR-34a and its regulation of p53 have been found to play a role in reducing fibrotic markers in fLfs. Increasing the expression of miR-34a can reduce the severity of lung fibrosis. Furthermore, treating fLfs with CSP or CSP7 can restore miR-34a expression and reduce expression of fibrotic markers.

ISCIENCE (2022)

Add to Collection

Review Engineering, Biomedical

Hydrogel and nanoparticle carriers for kidney disease therapy: trends and recent advancements

Xurui Gu et al.

Summary: This article summarizes the current trends and recent advancements in the development of carrier materials for kidney disease targeted therapies, specifically hydrogel and nanoparticle-based strategies for acute kidney disease, chronic kidney disease, and renal cell carcinoma. Additionally, it discusses the current limitations in carrier materials and their delivery mechanisms.

PROGRESS IN BIOMEDICAL ENGINEERING (2022)

Add to Collection

Article Pharmacology & Pharmacy

A phycocyanin derived eicosapeptide attenuates lung fibrosis development

Qihao Li et al.

Summary: PP20 has shown significant alleviation of inflammation and tissue destruction in pulmonary fibrosis, inhibiting EMT and reducing collagen fiber deposition. It can negatively regulate TGF-beta/Smad and MAPK pathways, showing anti-fibrotic properties.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Design and Evaluation of a Polypeptide That Mimics the Integrin Binding Site for EDA Fibronectin to Block Profibrotic Cell Activity

Lin Zhang et al.

Summary: The study focused on targeting the interactions between EDA-FN and its integrin receptors to inhibit profibrotic activity and myofibroblast formation. A blocking polypeptide, AF38Pep, was designed and synthesized for specific inhibition of EDA-FN associations with integrins alpha(4)beta(1) and alpha(4)beta(7). The results showed that AF38Pep effectively inhibited myofibroblast activity by preventing integrin-mediated signaling and reducing collagen synthesis and deposition.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases

Sergio Mallart et al.

Summary: This study involves the development of long-acting potent single-chain relaxin peptide mimetics by modifying the B-chain of relaxin, introducing specific mutations and trimming the sequence to an optimal size. These modifications resulted in potent, structurally simplified peptide agonists of the relaxin receptor RXFP1, with high subcutaneous bioavailability and extended half-lives, showing in vivo efficacy.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Assessment of renal fibrosis and anti-fibrotic agents using a novel diagnostic and stain-free second-harmonic generation platform

Sadman Bhuiyan et al.

Summary: This study compared the use of the HistoIndex platform for SHG imaging of renal fibrosis in UUO mice with traditional staining methods, finding that the platform provided more accurate quantification of renal fibrosis and evaluation of drug treatment effects. The platform also revealed additional insights into collagen morphology and distribution patterns, demonstrating its diagnostic value over currently used techniques.

FASEB JOURNAL (2021)

Add to Collection

Article Materials Science, Multidisciplinary

Natural polymeric and peptide-loaded composite wound dressings for scar prevention

Lin Zhang et al.

Summary: An innovative wound dressing has been developed to promote reduced-scar wound healing by selectively inhibiting pro-fibrotic cell phenotypes, attenuating inflammation, inhibiting fibroblast to myofibroblast differentiation, facilitating skin appendage regeneration, enhancing vascularization, and regulating favorable collagen deposition and distribution.

APPLIED MATERIALS TODAY (2021)

Add to Collection

Article Medicine, Research & Experimental

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects

Shailza Sharma et al.

Summary: The fibroproliferative disorders like systemic sclerosis have no effective therapies till now, but the C-terminal domain of endostatin called E4 has shown promising results in preventing and reversing dermal and pulmonary fibrosis. This study found that E4 works by regulating the urokinase pathway, increasing MMP-1 and MMP-3 levels, and binding to proteins like enolase-1 and uPA receptor to promote extracellular matrix degradation. Furthermore, the glycolytic enzyme enolase-1 plays a moonlighting function in fibrosis by mediating the effects of TGF-beta 1 and exerting TGF-beta 1-independent fibrotic effects.

JCI INSIGHT (2021)

Add to Collection

Article Immunology

Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model

Dilan Khalili et al.

Summary: The study reveals that expressing a dominant-active form of the Ras oncogene in Drosophila salivary glands leads to fibrotic lesions, which can be alleviated by the antimicrobial peptide drosomycin. This fibrotic lesion is characterized by disturbed basement membrane attracting clot components and a loss of cell polarity.

JOURNAL OF INNATE IMMUNITY (2021)

Add to Collection

Article Cell Biology

IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA

Sangmi Ock et al.

Summary: This study explores the role of IGF-1 signaling in cardiac fibrosis and suggests that low-dose IGF-1 may be an effective therapeutic against angiotensin II-induced cardiac fibrosis by inhibiting fibroblast proliferation, differentiation, and modulating the Akt pathway and ROCK2-mediated alpha-SMA expression.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Multidisciplinary Sciences

A deep-learning framework for multi-level peptide-protein interaction prediction

Yipin Lei et al.

Summary: The authors proposed a deep learning framework CAMP for predicting peptide-protein interactions and identifying important binding residues. Comprehensive evaluation showed that CAMP outperformed other methods in predicting peptide-protein interactions. CAMP serves as a significant tool in facilitating peptide drug discovery.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis

Yifan Tai et al.

Summary: Myofibroblasts play diverse roles in pathophysiological processes, with potential as therapeutic targets. Despite challenges in specifically targeting them, research is progressing towards understanding their formation, function, regulation, and developing interventions to prevent fibrosis and promote wound healing.

BIOMOLECULES (2021)

Add to Collection

Review Immunology

Transforming growth factor-beta in tissue fibrosis

Nikolaos G. Frangogiannis

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension

Mysuru Natarajan Savitha et al.

PEPTIDES (2020)

Add to Collection

Article Medicine, Research & Experimental

Investigating the potential of LSKL peptide as a novel hypertrophic scar treatment

Xiangwen Xu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Adiponectin-Based Peptide (ADP355) Inhibits Transforming Growth Factor-β1-Induced Fibrosis in Keloids

Claudia C. Darmawan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

A HGF-derived peptide suppresses EMT in human lens epithelial cells via the TGF-β/Smad and Akt/mTOR signaling pathways

Xiaobo Huang et al.

MOLECULAR MEDICINE REPORTS (2020)

Add to Collection

Article Oncology

Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway

Ruochen Qi et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Urology & Nephrology

Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy

Adam C. Midgley et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts

Yang Chen et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

RAP-8 ameliorates liver fibrosis by modulating cell cycle and oxidative stress

Hongjiao Xu et al.

LIFE SCIENCES (2019)

Add to Collection

Article Pharmacology & Pharmacy

M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation

Yan Li et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts

Felipe Tapia Caceres et al.

FASEB JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Inflammatory Transcription Factor C/EBP beta Plays a Critical Role in Cardiac Fibroblast Differentiation and a Rat Model of Cardiac Fibrosis Induced by Autoimmune Myocarditis

Xiu Li et al.

INTERNATIONAL HEART JOURNAL (2018)

Add to Collection

Article Materials Science, Biomaterials

In situ cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches

Muhammad Shafiq et al.

REGENERATIVE BIOMATERIALS (2018)

Add to Collection

Review Pharmacology & Pharmacy

Anti-fibrotic actions of relaxin

C. S. Samuel et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Hepatocyte Growth Factor Mediates Enhanced Wound Healing Responses and Resistance to Transforming Growth Factor-beta(1)-Driven Myofibroblast Differentiation in Oral Mucosal Fibroblasts

Jordanna Dally et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Add to Collection

Article Multidisciplinary Sciences

C/EBPβ-Thr217 Phosphorylation Stimulates Macrophage Inflammasome Activation and Liver Injury

Martina Buck et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Multidisciplinary Sciences

Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts

Keitaro Omori et al.

PLOS ONE (2016)

Add to Collection

Review Medicine, Research & Experimental

Role of the TGF-β/BMP-7/Smad pathways in renal diseases

Xiao-Ming Meng et al.

CLINICAL SCIENCE (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Transforming Growth Factor-β1 (TGF-β1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid Rafts

Adam C. Midgley et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Add to Collection

Review Oncology

The myofibroblast matrix: implications for tissue repair and fibrosis

Franco Klingberg et al.

JOURNAL OF PATHOLOGY (2013)

Add to Collection

Article Cell Biology

A Peptide Derived from Endostatin Ameliorates Organ Fibrosis

Yukie Yamaguchi et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts

Peng Li et al.

CIRCULATION RESEARCH (2008)

Add to Collection

Article Biochemistry & Molecular Biology

AMP-activated protein kinase inhibits transforming growth factor-β-induced Smad3-dependent transcription and myofibroblast transdifferentiation

Rangnath Mishra et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection

Article Physiology

ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells

Peng Li et al.

JOURNAL OF APPLIED PHYSIOLOGY (2007)

Add to Collection

Article Cell Biology

Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission

B Hinz

EUROPEAN JOURNAL OF CELL BIOLOGY (2006)

Add to Collection

Article Cell Biology

Focal adhesion size controls tension-dependent recruitment of α-smooth muscle actin to stress fibers

JM Goffin et al.

JOURNAL OF CELL BIOLOGY (2006)

Add to Collection

Article Cardiac & Cardiovascular Systems

Nitric oxide regulates transforming growth factor-β signaling in endothelial cells

M Saura et al.

CIRCULATION RESEARCH (2005)

Add to Collection

Review Oncology

The myofibroblast in wound healing and fibrocontractive diseases

G Gabbiani

JOURNAL OF PATHOLOGY (2003)

Add to Collection

Article Oncology

TGF-β1-mediated fibroblast-myofibroblast terminal differentiation -: the role of Smad proteins

RA Evans et al.

EXPERIMENTAL CELL RESEARCH (2003)

Add to Collection

Review Cell Biology

Myofibroblasts and mechano-regulation of connective tissue remodelling

JJ Tomasek et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.